lutein has been researched along with Triple Negative Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fauzi, AN; Muhammad, SNH; Safuwan, NAM; Yaacob, NS | 1 |
Gong, X; Rubin, LP; Smith, JR; Swanson, HM | 1 |
2 other study(ies) available for lutein and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Antiglycolytic Activities of
Topics: Acanthaceae; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glucose; Humans; Lactates; Lutein; Plant Extracts; Stigmasterol; Triple Negative Breast Neoplasms | 2022 |
Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Bridged-Ring Compounds; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Epithelial Cells; Female; Humans; Lutein; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Taxoids; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53 | 2018 |